Navigation Links
Arcion Therapeutics Receives FDA Fast Track Designation for ARC-4558 for the Treatment of Pain Associated with Painful Diabetic Neuropathy
Date:9/14/2010

ough its agonist effects on alpha2 (a2)-adrenergic receptors, is believed to reduce pain in PDN via local actions on the nociceptors that innervate the affected skin. Based on the results of clinical trials to-date, Arcion believes that ARC-4558 has a level of efficacy comparable to systemic therapies in the target population, but with substantially fewer side effects. The 0.1% gel formulation avoids the treatment area limitations and undesirable aesthetic and skin reaction issues associated with analgesic patches. Furthermore, the ARC-4558 gel has been shown to provide analgesia without numbing or anesthetizing the skin.

About Painful Diabetic Neuropathy (PDN)

Neuropathy is a common complication of diabetes mellitus. According to 2008 estimates by the Centers for Disease Control and Prevention, nearly 18 million people in the United States are diagnosed with diabetes. Given a conservative estimate that 15% of people with diabetes have painful neuropathies, approximately 2.7 million Americans experience PDN. Patients with PDN often experience debilitating pain symptoms that affect day-to-day functioning and quality of life.  How diabetes causes a length-dependent neuropathy is unknown.  Arcion believes the PDN market is highly under-served by existing products and that there is a strong scientific rationale for developing a topical treatment for PDN that delivers analgesia in a way that avoids systemic side effects.

About Arcion

Arcion Therapeutics applies breakthroughs in neuroscience to advance the treatment of chronic pain. The company focuses on innovative topical treatments to provide pain relief with convenient application and reduced systemic side effects. Arcion's product pipeline comprises multiple candidates to treat neuropathic pain.  www.arciontherapeutics.com


'/>"/>
SOURCE Arcion Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Arcion Therapeutics Topical Gel Candidate, ARC-4558, Demonstrates Significant Pain Reduction in Phase 2b Trial for Painful Diabetic Neuropathy (PDN)
2. Anesiva Announces Merger With Arcion Therapeutics Will Not be Completed
3. Arcion Therapeutics Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy
4. Orexigen® Therapeutics to Speak at Rodman & Renshaw Annual Global Investment Conference
5. Halozyme Therapeutics Announces Public Offering of Common Stock
6. Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics
7. Precision Therapeutics, Inc. Named to Pittsburgh Business Times 2010 Top 100
8. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
9. Reportlinker Adds Urological Disorders Therapeutics to 2016 - Increasing Awareness and Aging Population will Drive the Benign Prostatic Hyperplasia and Urinary Incontinence Markets
10. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
11. Echo Therapeutics Announces Successful Completion of Clinical Trial for Prelude™ SkinPrep System and 4% Lidocaine Cream
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015   Heska ... "Company"), a provider of  advanced veterinary diagnostic and ... availability of the new Element i ® ... and screening for key health concerns, including thyroid ... i is a compact bench top analyzer that ...
(Date:7/28/2015)... -- Psychemedics Corporation (NASDAQ: PMD ) today announced second ... 2015.  The Company also announced a quarterly dividend of ... of August 7, 2015 to be paid on August ... consecutive quarterly dividend. The Company,s revenue ... million versus $7.7 million for the quarter ended June ...
(Date:7/28/2015)... Calif. , July 28, 2015  Nevro ... device company that is providing innovative evidence-based solutions ... the publication of the SENZA-RCT results in the ... Journal of the American Society of Anesthesiologists. ... ground-breaking study that was the first to directly ...
Breaking Medicine Technology:Heska Announces Veterinary Market's first and only point of care Analyzer for TSH, Total T4, and Cortisol results in minutes 2Heska Announces Veterinary Market's first and only point of care Analyzer for TSH, Total T4, and Cortisol results in minutes 3Psychemedics Corporation Announces Second Quarter Earnings 2Psychemedics Corporation Announces Second Quarter Earnings 3Psychemedics Corporation Announces Second Quarter Earnings 4Psychemedics Corporation Announces Second Quarter Earnings 5Psychemedics Corporation Announces Second Quarter Earnings 6Psychemedics Corporation Announces Second Quarter Earnings 7Psychemedics Corporation Announces Second Quarter Earnings 8Nevro Announces Publication of SENZA-RCT Results in Anesthesiology 2
... JERSEY CITY, New Jersey and PHILADELPHIA, December 11, ... microRNA-based molecular diagnostics, announced today the,commercial availability of ... now commercially available through Rosetta Genomics,CLIA-certified lab in ... To order the test, physicians may contact 1-888-522-7971, ...
... VEGAS, Dec. 11 CardioVascular BioTherapeutics, Inc. (OTC Bulletin Board: ... States opened for patient enrollment for its ACORD Phase II ... The sites are Minneapolis Heart Institute Foundation in Minneapolis MN, ... , , Mercy Hospital Fairfield ...
Cached Medicine Technology:Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 2Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 3Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 4Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 5CVBT Opens Two Additional Sites for Patient Enrollment for Phase II Heart Trial 2
(Date:7/28/2015)... , ... July 28, 2015 , ... ... Total Heart Center at Memorial Regional Hospital, providing expert, streamlined total advanced heart ... be suited to provide extensive heart services under one roof, including the treatment ...
(Date:7/28/2015)... ... July 28, 2015 , ... The Triumph Modular, Redefining ... consumer education, resource library, floor plans, educational blog and wide use of imagery. ... regular posts with valuable links to useful reports by industry experts. Comments are ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... products, announces the Lost and Found, a breakthrough technological invention. It is ... "Revenue for the consumer electronic industry reached a record high of $211.3 billion ...
(Date:7/28/2015)... ... July 28, 2015 , ... Morristown Medical Center, part of Atlantic ... of the first five hospitals in the nation, to implant the newly approved CoreValve® ... 23, and all are in good condition. , The CoreValve® Evolut® R System was ...
(Date:7/28/2015)... Ethiopia (PRWEB) , ... July 28, 2015 , ... ... during U.S. President Barack Obama’s visit to Ethiopia to learn more about the ... the Future Initiative . This initiative focuses on accelerating agricultural development as an ...
Breaking Medicine News(10 mins):Health News:Memorial Cardiac And Vascular Institute Centralizes Cardiac Care Through It's New "Total Heart Center" At Memorial Regional Hospital 2Health News:Triumph Modular Launches Refreshed Modular Building Industry Website 2Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 2Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 3Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 4Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 5Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4
... therapy, higher death risk , WEDNESDAY, April 28 (HealthDay News) ... study was abruptly halted in 2008 when researchers noticed an ... who were being intensively treated to bring their blood sugar ... analysis of data from that study has concluded that a ...
... researchers from the University of Bristol and a large group ... Collaboration (ART-CC) which involved nearly 40,000 patients who started ART ... Of the 1,876 deaths that occurred in that time, a ... cases. Overall, almost 50% of patients died from AIDS which ...
... ... only the satisfaction of helping others, but praise for his work. The Nassau Guardian ... recognized for the estimated 10 million meals, 30 palettes of water, and millions of ... , ...
... ... Eye market is huge and growing valued at 1.7 billion USD in 2009 with an annual ... billion USD by 2014. , ... (PRWEB) April 28, 2010 -- Dry eye disease (DED) is one of the most frequently encountered ...
... , ... study published Monday in Thymos: Journal of Boyhood Studies estimates that more than 100 ... and infection. Because infant circumcision is elective, all of these deaths are avoidable. ... (PRWEB) April 28, ...
... ... enabling URS Tax Inc. ( http://www.urstax.com ) to securely store, protect and manage a variety ... tax preparation time. , , ... (PRWEB) April 28, 2010 -- URS Tax Inc. is a tax preparation and consulting firm ...
Cached Medicine News:Health News:Tight Blood Sugar Control May Not Harm Diabetics 2Health News:Tight Blood Sugar Control May Not Harm Diabetics 3Health News:Causes of death in AIDS patients 2Health News:Philanthropy At Its Finest - Yank Barry 2Health News:CBDM.T, The Market and Business Intelligence Company Reviews The Dry Eye Disease Treatment Market 2Health News:CBDM.T, The Market and Business Intelligence Company Reviews The Dry Eye Disease Treatment Market 3Health News:Children's Rights Group Agrees with New Study: Infant Circumcision Causes 100 Deaths Each Year in US 2Health News:FileHold Document Management Software Helps National Tax Consulting Firm Reduce Paper and Streamline Tax Preparation for Their Clients 2Health News:FileHold Document Management Software Helps National Tax Consulting Firm Reduce Paper and Streamline Tax Preparation for Their Clients 3
... is the newest technology available in acrylic ... combines exceptional material and design properties to ... Biostability , Unique foldable hydrophobic acrylic material ... be biostable , High index of ...
12 mm single use, reloadable laparoscopic linear stapler with titanium staples....
Single Use Loading Units (SULU's) Knifeless for use with MULTIFIRE ENDO GIA™ 30 12 mm (Single Use Staplers with Titanium Staples)....
... Single use loading unit for reloadable rotating ... transection and anastomosis with titanium staples., ... of titanium staples and simultaneously the knife ... is designed for multiple use during a ...
Medicine Products: